89BIO, INC.
Clinical trial NCT05852431 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-01 → 2026-04-09 3. enrollment: 360 → 369 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05852431 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-01 → 2026-04-09 3. enrollment: 360 → 369 participants 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical